Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/14/2003WO2003066869A1 Lmt tumor suppressor gene
08/14/2003WO2003066868A1 Retroviral vectors pseudotyped with influenza virus hemagglutinin for gene delivery
08/14/2003WO2003066866A2 Cultivation method of transgenic plants for lycopene cyclase
08/14/2003WO2003066865A2 Nucleic acid molecule for regulation of gene expression in plants
08/14/2003WO2003066864A2 Method for predicting the expression efficiency in cell-free expression systems
08/14/2003WO2003066863A1 α-SUBSTITUTED-α,β-UNSATURATED CARBONYL COMPOUND REDUCTASE GENE
08/14/2003WO2003066862A1 Cloning of a human prolylhydroxylase-like protein
08/14/2003WO2003066861A1 Intein-mediated protein splicing
08/14/2003WO2003066860A1 Angiogenesis inhibitors
08/14/2003WO2003066858A1 Trans-splicing ribozymes transferring elements derived from sequences encoding fluorescent proteins
08/14/2003WO2003066857A2 Elements for modulating plant dna replication, transformation rate, cell cycle regulation and growth
08/14/2003WO2003066855A1 Swine rag-1 gene and utilization thereof
08/14/2003WO2003066853A1 Identifying dna molecules or proteins involved in producing natural products
08/14/2003WO2003066852A2 Plant growth modulation by drl1 and other proteins of the elongator complex
08/14/2003WO2003066847A2 Phytase variants
08/14/2003WO2003066846A1 Methods for modifying plant responses to stress and correspondingly derived plants
08/14/2003WO2003066845A2 Bacteriophage lysin
08/14/2003WO2003066842A2 Method for producing recombinant proteins in micro-organisms
08/14/2003WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003WO2003066838A1 A process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis
08/14/2003WO2003066836A2 Udp-glucosyltransferases
08/14/2003WO2003066828A2 Zinc finger libraries
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066823A2 Prevention of transgene escape in genetically modified perennials
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066818A2 Secretion, transcription and sporulation genes in bacillus clausii
08/14/2003WO2003066813A2 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE
08/14/2003WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003WO2003066809A2 Mismatch endonucleases and methods of use
08/14/2003WO2003066805A2 Antisense modulation of complement component c3 expression
08/14/2003WO2003066804A2 Thermus scotoductus nucleic acid polymerases
08/14/2003WO2003066802A2 Gene expression analysis using nicking agents
08/14/2003WO2003066801A2 Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system.
08/14/2003WO2003066676A1 Production process of recombinant placental growth factor
08/14/2003WO2003066675A1 Gene conferring resistance to phytophthora infestans (late-blight) in solanacea
08/14/2003WO2003066667A2 Method and apparatus for performing submicroliter reactions with nucleic acids or proteins
08/14/2003WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency
08/14/2003WO2003066661A2 Human dr4 antibodies and uses thereof
08/14/2003WO2003066650A2 Short interfering rna molecules directed towards a tissue factor coding nucleic acid
08/14/2003WO2003066649A1 Immunostimulatory, covalently lipidated oligonucleotides
08/14/2003WO2003066108A1 Inactivation of microbes in biological fluids
08/14/2003WO2003066093A1 A continuous cell line for the production of vaccines
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066090A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066082A1 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066076A1 Method of protecting living body from foreign factor and composition therefor
08/14/2003WO2003066068A1 Hpma-polyamine conjugates and uses therefore
08/14/2003WO2003066048A2 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003065984A2 Methods and compositions for treating cardiovascular disease
08/14/2003WO2003065977A2 Modified antigen-presenting cells
08/14/2003WO2003065973A2 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003WO2003065871A2 Methods and compositions for treating hematological disorders
08/14/2003WO2003065870A2 Digital amplification for detection of mismatch repair deficient tumor cells
08/14/2003WO2003065795A2 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
08/14/2003WO2003065793A2 Generation of multiple embryo maize
08/14/2003WO2003050240A3 Expression system
08/14/2003WO2003048319A3 Nucleotide sequences encoding proteins conferring abiotic stress tolerance in plants
08/14/2003WO2003048309A3 Thermus thermophilus nucleic acid polymerases
08/14/2003WO2003047617A3 Vaccine
08/14/2003WO2003044216A3 Multiplex oligonucleotide addition and target amplification
08/14/2003WO2003041652A3 Method of using 18080, a human serine carboxypeptidase family member
08/14/2003WO2003040352A9 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
08/14/2003WO2003040342A3 Method for generation of modular polynucleotides using solid supports
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2003031934A3 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis b viral dna
08/14/2003WO2003031929A3 Devices and methods for detecting genetic sequences
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003029924A3 Adaptive baseline algorithm for quantitative pcr
08/14/2003WO2003029433A3 Chimeric viral vectors for gene therapy
08/14/2003WO2003028637A3 Antisense modulation of sphingosine-1-phosphate lyase expression
08/14/2003WO2003026395A3 Mo54 gene disruptions, compositions and methods related thereto
08/14/2003WO2003025118A3 Multi-site mutagenesis
08/14/2003WO2003023365A3 Electrochemical sensor using intercalative, redox-active moieties
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003018764A3 Novel human proteases and polynucleotides encoding the same
08/14/2003WO2003017935A3 Human antibodies specific for interleukin 15 (il-15)
08/14/2003WO2003014373A3 Metal-binding proteins
08/14/2003WO2003012051A8 Inhibitor of dna methylation
08/14/2003WO2003009813A3 Methods of treating neuropilin-mediated diseases
08/14/2003WO2003008631A3 Tagging of microorganisms
08/14/2003WO2003005810A3 Cloned non-human mammals from contact inhibited donor cells
08/14/2003WO2003002713A3 Antibodies to opgl
08/14/2003WO2003002069A3 Intradermal delivery of vaccines and gene therapeutic agents via microcannula
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002097102A3 Modification of plant genomes by inducible site-specific recombination of trans genes
08/14/2003WO2002092849A3 Methods
08/14/2003WO2002088341A3 P450 proteins
08/14/2003WO2002086098A3 A lac operator-repressor system
08/14/2003WO2002083902A3 Adenovirus serotype 30 (ad30) fiber protein and uses thereof
08/14/2003WO2002079416A3 Transgenic animals resistant to transmissible spongiform encephalopathies
08/14/2003WO2002079241A3 Secreted streptococcus pneumoniae proteins
08/14/2003WO2002072803A3 Subgenomic replicons of the flavivirus dengue